Quality-of-life outcomes for men with prostate carcinoma detected by screening

Cancer

Volumn 88, Issue 6, 2000, Pages 1454-1463

  Smith, Deborah S ^a   Carvalhal, Gustavo F ^a   Schneider, Kay ^a   Krygiel, Julie ^a   Yan, Yan ^a   Catalona, William J ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Urologic Surgery   (United States)

Author keywords

Outcomes; Prostatic neoplasms; Quality of life; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; EARLY DIAGNOSIS; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; SEXUAL FUNCTION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS, HORMONAL; ATTITUDE TO HEALTH; CARCINOMA; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; CRYOSURGERY; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TREATMENT OUTCOME; URINATION DISORDERS;

EID: 0034653911     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000315)88:6<1454::AID-CNCR25>3.0.CO;2-S     Document Type: Article

References (32)

1. Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 1982; 128:492-7.
2. Lu-Yao GL, Greenberg ER. Change in prostate cancer incidence and treatment in USA. Lancet 1994;343:251-4.
3. Lu-Yao GL, Friedman M, Yao S. Population-based study of long-term survival in patients with clinically localized prostate cancer. Lancet 1997;349:906-10.
4. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994;152:1831-6.
5. Catalona WJ, Basler JW. Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol 1993;150:905-7.
6. Zincke H, Oesterling JE, Blute ML, Bergstralh EJ, Myers RP, Barrett DM. Long-term (15 years) results after radical retropubic prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 1994;152:1850-7.
7. Lerner SE, Blute ML, Lieber MM, Zincke H. Morbidity of contemporary radical retropubic prostatectomy for localized prostate cancer. Oncology 1995;9:379-89.
8. Fowler FJ Jr, Barry MJ, Lu-Yao G, Roman A, Wasson J, Wennberg JE. Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993). Urology 1993;42:622-9.
9. Fowler FJ Jr, Barry MJ, Lu-Yao G, Wasson J, Roman A, Wennberg J. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology 1995;45:1007-15.
10. Mettlin CJ, Murphy GP, Sylvester J, McKee RF, Morrow M, Winchester DP. Results of hospital cancer registry surveys by the American College of Surgeons: outcomes of prostate cancer treatment by radical prostatectomy. Cancer 1997;80: 1875-81.
11. Gaylis FD, Friedel WE, Armas OA. Radical retropubic prostatectomy outcomes at a community hospital. J Urol 1998; 159:167-71.
12. Robinson JW, Dufour MS, Fung TS. Erectile functioning of men treated for prostate carcinoma. Cancer 1997;79:538-44.
13. Shrader-Bogen CL, Kjellberg JL, McPherson CP, Murray CL. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiotherapy. Cancer 1997;79:1977-86.
14. Long JP, Fallick ML, LaRock DR, Rand W. Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma. J Urol 1998;159:477-84.
15. Herr HW. Quality of life in prostate cancer patients. CA Cancer J Clin 1997;47:207-17.
16. Albertsen PC, Aaronson NK, Keller SD, Ware JE Jr. Health-related quality of life among patients with metastatic prostate cancer. Urology 1997;49:207-17.
17. Borghede G, Karlsson J, Sullivan M. Quality of life in patients with prostatic cancer: results from a Swedish population study. J Urol 1997;158:1477-86.
18. Arterberry VE, Frazier A, Dalmia P, Siefer J, Lutz M, Porter A. Quality of life after permanent prostate implant. Semin Surg Oncol 1997;13:461-4.
19. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, et al. Quality of life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129-35.
20. Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1993;270:948-54.
21. Smith DS, Humphrey PA, Catalona WJ. The early detection of prostate carcinoma with prostate specific antigen. The Washington University Experience. Cancer 1997;80:1852-6.
22. Smith DS, Catalona WJ, Herschman JD. Longitudinal screening for prostate cancer with prostate specific antigen. JAMA 1996;276:1309-15.
23. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;324:1156-61.
24. Smith DS, Bullock AD, Catalona WJ, Herschman JD. Racial differences in a prostate cancer screening study. J Urol 1996;156:1366-9,
25. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al, editors. American Joint Committee on Cancer staging manual. 5th edition. Philadelphia: J. B. Lippincott, 1997.
26. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ 1993;2:217-27.
27. McHorney CA, Ware JE Jr, Lu JFR, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
28. Carvalhal GF, Smith DS, Ramos C, Krygiel J, Mager DE, Yan Y, Catalona WJ. Correlates of dissatisfaction with treatment in patients with prostate cancer diagnosed through screening. J Urol. 1999;162:113-8.
29. SAS/STAT User's Guide. Version 6, 4th edition, Volume 2. Cary, NC: SAS Institute Inc.,1990.
30. Catalona WJ, Carvalhal GF, Mager DE, Smith DS. Potency, continence, and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol. 1999;162:433-8.
31. Potosky AL, Legler JM, Gilliland FD, Albuquerque NM, Deapen D, Stephenson RA, et al. The prostate cancer outcomes study (PCOS): reliability of disease-specific quality of life [Abstract 990, 93rd Annual Meeting of the American Urological Association, San Diego, CA, May 30-June 4, 1998]. J Urol 1998;159(Suppl):258.
32. Albertsen PC, Nease RF Jr, Potosky AL. Assessment of patient preferences among men with prostate cancer. J Urol 1998;159:158-63.